Lymphocytes, especially CD4+ T cells, are essential for clearance of the yeast-like organism Cryptococcus neoformans from the infected host. The mechanism(s) by which the lymphocytes facilitate elimination of cryptococci has not been elucidated. It is generally thought, however, that lymphocytes reactive with C. neoformans indirectly function by production of lymphokines to enhance clearance of the organism by natural effector cells such as macrophages. In the present study, we assessed the ability of freshly isolated human lymphocytes to interact directly with C. neoformans and to limit the growth of the organism in vitro. We found that large granular lymphocytes (LGL) as well as T cells bound to cryptococcal cells when the lymphocytes were mixed with the cryptococcal cells at a 2:1 ratio. The physical binding interactions of the two lymphocyte populations were different. LGL attached to the cryptococcal cells by many microvilli; T lymphocytes associated with the yeast through broad areas of membrane attached to the cryptococcal cell surface. The two types of lymphocyte interactions did not result in phagocytosis but resulted in direct inhibition of cryptococcal growth, making these lymphocyte interactions with cryptococci distinctly different from interactions of monocytes with cryptococci. With the human natural killer (NK) cell line, NK 3.3, we confirmed that NK cells that were present in the LGL population were capable of limiting the growth of C. neoformans. Through immunoelectron microscopy, human CD3+ lymphocytes were seen attached to cryptococcal cells and by mass cytolysis, human CD3+ lymphocytes were shown to be responsible for inhibition of C. neoformans growth. The direct inhibitory interactions of NK cells and T lymphocytes with cryptococcal cells may be important means of host defense against this ubiquitous organism that frequently causes life-threatening disease in AIDS patients.
J W Murphy, M R Hidore, S C Wong
Title and authors | Publication | Year |
---|---|---|
State of the Field: Cytotoxic Immune Cell Responses in C. neoformans and C. deneoformans Infection.
Okafor EC, Nielsen K |
Journal of fungi (Basel, Switzerland) | 2024 |
Cryptococcus neoformans Infection in the Central Nervous System: The Battle between Host and Pathogen.
Chen Y, Shi ZW, Strickland AB, Shi M |
2022 | |
Granulysin: killer lymphocyte safeguard against microbes
F Dotiwala, J Lieberman |
Current Opinion in Immunology | 2019 |
Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida
SS Li, H Ogbomo, MK Mansour, RF Xiang, L Szabo, F Munro, P Mukherjee, RA Mariuzza, M Amrein, JM Vyas, SM Robbins, CH Mody |
Nature Communications | 2018 |
Combination of nutrients in a mammalian cell culture medium kills cryptococci
DL Granger, DM Call |
Medical Mycology | 2018 |
Granule-Dependent NK Cell Killing of Cryptococcus Requires Kinesin to Reposition the Cytolytic Machinery for Directed Cytotoxicity
H Ogbomo, M Timm-McCann, T Barnes, RF Xiang, K Jamil, A Ganguly, D Stack, SM Huston, SS Li, P Colarusso, CH Mody |
Cell Reports | 2018 |
Adaptive Immunity to Cryptococcus neoformans Infections
L Mukaremera, K Nielsen |
Journal of Fungi | 2017 |
Innate Immune Responses to Cryptococcus
L Heung |
Journal of Fungi | 2017 |
Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients
SK Kyei, H Ogbomo, SS Li, M Timm-McCann, RF Xiang, SM Huston, A Ganguly, P Colarusso, MJ Gill, CH Mody |
mBio | 2016 |
Recent Trends in Antifungal Agents and Antifungal Therapy
SS Rathore, J Ramakrishnan, T Raman |
Recent Trends in Antifungal Agents and Antifungal Therapy | 2016 |
New technology and resources for cryptococcal research
N Zhang, YD Park, PR Williamson |
Fungal Genetics and Biology | 2014 |
The Intracellular Life of Cryptococcus neoformans
C Coelho, AL Bocca, A Casadevall |
Annual review of pathology | 2014 |
The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients
SS Li, SK Kyei, M Timm-McCann, H Ogbomo, GJ Jones, M Shi, RF Xiang, P Oykhman, SM Huston, A Islam, MJ Gill, SM Robbins, CH Mody |
Cell Host & Microbe | 2013 |
Natural killer cells and antifungal host response
S Schmidt, SY Zimmermann, L Tramsen, U Koehl, T Lehrnbecher |
Clinical and vaccine immunology : CVI | 2013 |
Requirement and Redundancy of the Src Family Kinases Fyn and Lyn in Perforin-Dependent Killing of Cryptococcus neoformans by NK Cells
P Oykhman, M Timm-McCann, RF Xiang, A Islam, SS Li, D Stack, SM Huston, LL Ma, CH Mody, GS Deepe |
Infection and immunity | 2013 |
Experimental Models of Cryptococcosis
W Sabiiti, RC May, ER Pursall |
International journal of microbiology | 2012 |
Host Defenses Against Cryptococcosis
MS Price, JR Perfect |
Immunological Investigations | 2011 |
CD4+and CD8+T cells mediated direct cytotoxic effect againstTrichophyton rubrumandTrichophyton mentagrophytes
A Waldman, R Segal, I Berdicevsky, A Gilhar |
International Journal of Dermatology | 2010 |
Direct Microbicidal Activity of Cytotoxic T-Lymphocytes
P Oykhman, CH Mody |
Journal of Biomedicine and Biotechnology | 2010 |
Combating Fungal Infections
I Ahmad, M Owais, M Shahid, F Aqil |
2010 | |
Cryptococcus: From Human Pathogen to Model Yeast
J Heitman, TR Kozel, KJ Kwon-Chung, JR Perfect, A Casadevall |
2010 | |
Clinical Mycology
M Donoghue, NL Seibel, PS Francis, TJ Walsh |
Clinical Mycology | 2009 |
Cryptococcus neoformans Directly Stimulates Perforin Production and Rearms NK Cells for Enhanced Anticryptococcal Microbicidal Activity
KJ Marr, GJ Jones, C Zheng, SM Huston, M Timm-McCann, A Islam, BM Berenger, LL Ma, JC Wiseman, CH Mody |
Infection and immunity | 2009 |
Human and Animal Relationships
AA Brakhage, PF Zipfel |
2008 | |
Immunology of Fungal Infections
GD Brown, MG Netea |
2007 | |
Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP
PC Lin, LT Hsiao, SB Poh, WS Wang, CC Yen, TC Chao, JH Liu, TJ Chiou, PM Chen |
Annals of Hematology | 2006 |
Contemplating the murine test tube: lessons from natural killer cells and Cryptococcus neoformans
KJ Marr, GJ Jones, CH Mody |
FEMS Yeast Research | 2006 |
Toxicity to Candida albicans mediated by human serum and peripheral blood mononuclear cells
JM Bliss, SS Laforce-Nesbitt |
FEMS Immunology and Medical Microbiology | 2006 |
Molecular Principles of Fungal Pathogenesis
J Heitman, SG Filler, JE Edwards, AP Mitchell |
2006 | |
Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients
CF Zheng, LL Ma, GJ Jones, MJ Gill, AM Krensky, P Kubes, CH Mody |
Blood | 2006 |
Cell-mediated adaptive immune defense of the lungs
JL Curtis |
Proceedings of the American Thoracic Society | 2005 |
The immune response to fungal infections
S Shoham, SM Levitz |
British Journal of Haematology | 2005 |
Fungal Immunology
PL Fidel, GB Huffnagle |
2005 | |
NK Cells Use Perforin Rather than Granulysin for Anticryptococcal Activity
LL Ma, CL Wang, GG Neely, S Epelman, AM Krensky, CH Mody |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Identification of App1 as regulator of phagocytosis and virulence of Cryptococcus neoformans
Chiara Luberto, Beatriz Martinez-Mariño, Daniel Taraskiewicz, Benjamin Bolaños, Pasquale Chitano, Dena L. Toffaletti, Gary M. Cox, John R. Perfect, Yusuf A. Hannun, Edward Balish, Maurizio Del Poeta |
Journal of Clinical Investigation | 2003 |
Chemokine-mediated recruitment of natural killer cells is a critical host defense mechanism in invasive aspergillosis
Brad E. Morrison, Stacy J. Park, Jill M. Mooney, Borna Mehrad |
Journal of Clinical Investigation | 2003 |
Complementation of a Capsule Deficient Cryptococcus neoformans with Cap64 Restores Virulence in a Murine Lung Infection
JA Wilder, GK Olson, YC Chang, KJ Kwon-Chung, MF Lipscomb |
American journal of respiratory cell and molecular biology | 2002 |
CD8 T Cell-Mediated Killing of Cryptococcus neoformans Requires Granulysin and Is Dependent on CD4 T Cells and IL-15
LL Ma, JC Spurrell, JF Wang, GG Neely, S Epelman, AM Krensky, CH Mody |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
Lymphocyte Adhesion to Candida albicans
CB Forsyth, HL Mathews |
Infection and immunity | 2002 |
Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus
DL Shieh |
Journal of Neurovirology | 2001 |
NK Cells Eliminate Cryptococcus neoformans by Potentiating the Fungicidal Activity of Macrophages Rather than by Directly Killing Them upon Stimulation with IL-12 and IL-18
K Kawakami, Y Koguchi, MH Qureshi, S Yara, Y Kinjo, K Uezu, A Saito |
Microbiology and Immunology | 2000 |
Host defence to pulmonary mycosis
CH Mody, PW Warren |
The Canadian Journal of Infectious Diseases | 1999 |
The Cell Wall and Membrane of Cryptococcus neoformans Possess a Mitogen for Human T Lymphocytes
TR Kozel, CH Mody, CJ Wood, RM Syme, JC Spurrell |
Infection and immunity | 1999 |
Mechanisms for Induction of L-Selectin Loss from T Lymphocytes by a Cryptococcal Polysaccharide, Glucuronoxylomannan
TR Kozel, ZM Dong, L Jackson, JW Murphy |
Infection and immunity | 1999 |
Activated lymphocytes reduce adherence of Aspergillus fumigatus
MARTINS, RODRIGUEZ, SAVARY, GRAZZIUTTI, DESHPANDE, COHEN, COWART, WOODSIDE, McINTYRE, ANAISSIE, REX |
Medical Mycology | 1998 |
Activated lymphocytes reduce adherence ofAspergillus fumigatus
MD Martins, LJ Rodriguez, CA Savary, ML Grazziutti, D Deshpande, DM Cohen, RE Cowart, DG Woodside, BW Mcintyre, EJ Anaissie, JH Rex |
Medical Mycology | 1998 |
Role of the capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not of secretory functions
R Barluzzi, A Brozzetti, D Delfino, F Bistoni, E Blasi |
Medical Mycology | 1998 |
Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes
A Vecchiarelli, C Monari, C Retini, D Pietrella, B Palazzetti, L Pitzurra, A Casadevall |
European Journal of Immunology | 1998 |
Role of the capsule in microglial cell- Cryptococcus neoformans interaction: impairment of antifungal activity but not of secretory functions
R Barluzzi, A Brozzetti, D Delfino, F Bistoni, E Blasi |
Medical Mycology | 1998 |
Role of the capsule in microglial cell—Cryptococcus neoformansinteraction: impairment of antifungal activity but not of secretory functions
R Barluzzi, A Brozzetti, D Delfino, F Bistoni, E Blasi |
Medical Mycology | 1998 |
Interaction between Human Interleukin-2-Activated Natural Killer Cells and Heat-Killed Germ Tube Forms ofCandida albicans
G Arancia, A Stringaro, P Crateri, A Torosantucci, C Ramoni, F Urbani, CM Ausiello, A Cassone |
Cellular Immunology | 1998 |
Cryptococcus neoformans
A Casadevall, JR Perfect |
1998 | |
Antigen-Induced Protective and Nonprotective Cell-Mediated Immune Components against Cryptococcus neoformans
JW Murphy, F Schafer, A Casadevall, A Adesina |
Infection and immunity | 1998 |
Activation of Natural Killer Cells in Arthritis-Susceptible but Not Arthritis-Resistant Mouse Strains following Borrelia burgdorferi Infection
JM Mansfield, CR Brown, SL Reiner |
Infection and immunity | 1998 |
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells
W Chaka, AF Verheul, VV Vaishnav, R Cherniak, J Scharringa, J Verhoef, H Snippe, IM Hoepelman |
Infection and immunity | 1997 |
Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production
JW Murphy, A Zhou, SC Wong |
Infection and immunity | 1997 |
Prospects for the development of fungal vaccines
GS Deepe |
Clinical microbiology reviews | 1997 |
Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans
C Monari, F Baldelli, D Pietrella, C Retini, C Tascini, D Francisci, F Bistoni, A Vecchiarelli |
Journal of Infection | 1997 |
Immunoregulation in Health and Disease
L Tomašević, E Maggi, S Romagnani |
Immunoregulation in Health and Disease | 1997 |
History of medical mycology in the united states
A Espinel-Ingroff |
Clinical microbiology reviews | 1996 |
gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans
SM Levitz, EA North |
Infection and immunity | 1996 |
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils
C Retini, A Vecchiarelli, C Monari, C Tascini, F Bistoni, TR Kozel |
Infection and immunity | 1996 |
Effect of d-fenfluramine on the local immune response to the opportunistic microbial pathogen Candida albicans
HL Mathews, SA Lorens, J Clancy |
Behavioural Brain Research | 1995 |
Direct antimicrobial activity of T cells
SM Levitz, HL Mathews, JW Murphy |
Immunology Today | 1995 |
The role of natural killer cells in host—parasite interactions
P Scott, G Trinchieri |
Current Opinion in Immunology | 1995 |
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
TG Mitchell, JR Perfect |
Clinical microbiology reviews | 1995 |
Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice
SM Muth, JW Murphy |
Infection and immunity | 1995 |
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis
R Cherniak, LC Morris, T Belay, ED Spitzer, A Casadevall |
Infection and immunity | 1995 |
Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes
SM Levitz, EA North, MP Dupont, TS Harrison |
Infection and immunity | 1995 |
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes
A Vecchiarelli, C Retini, D Pietrella, C Monari, C Tascini, T Beccari, TR Kozel |
Infection and immunity | 1995 |
Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans
G Arancia, A Molinari, P Crateri, A Stringaro, C Ramoni, ML Dupuis, MJ Gomez, A Torosantucci, A Cassone |
Infection and immunity | 1995 |
Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody
SC Lee, Y Kress, DW Dickson, A Casadevall |
Journal of Neuroimmunology | 1995 |
CD4 lymphocyte count in HIV positive persons exposed to cryptococcus neo formans
K Arasteh, M L’age, U Futh, G Grosse, F Staib |
Zentralblatt für Bakteriologie | 1995 |
The regulation of pulmonary immunity.
Lipscomb MF, Bice DE, Lyons CR, Schuyler MR, Wilkes D |
Advances in immunology | 1995 |
Biochemical basis for the killing ofCryptococcus neoformansby rat peritoneal cells
GR Rossi, DA Sastre, HR Rubinstein, DT Masih |
Medical Mycology | 1994 |
Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans
SM Levitz, MP Dupont, EH Smail |
Infection and immunity | 1994 |
Polysaccharide antigens of the capsule of Cryptococcus neoformans
R Cherniak, JB Sundstrom |
Infection and immunity | 1994 |
The role of natural killer cells in innate resistance to infection
GJ Bancroft |
Current Opinion in Immunology | 1993 |
A T cell-independent protective host response against Cryptococcus neoformans expressed at the primary site of infection in the lung
JO Hill, PL Dunn |
Infection and immunity | 1993 |
Drugs of Abuse, Immunity, and AIDS
H Friedman, TW Klein, S Specter |
1993 |